ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum
American Society of Retina Specialists (ASRS)
49 episodes
1 month ago
On this episode of the JVRD Author's Forum podcast, Dr. Ivan Suñer of Retina Associates of Florida discusses "Coring of Intravitreal Medication Vial Stoppers: A Report from the REST Committee," published in the September/October 2025 issue of the Journal of VitreoRetinal Diseases. Host Dr. Timothy Murray and Dr. Suñer review how vigilant ASRS members reported unusual black material in medication vials that was initially suspected to be fungal contamination but was identified as ru...
All content for ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum is the property of American Society of Retina Specialists (ASRS) and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
On this episode of the JVRD Author's Forum podcast, Dr. Ivan Suñer of Retina Associates of Florida discusses "Coring of Intravitreal Medication Vial Stoppers: A Report from the REST Committee," published in the September/October 2025 issue of the Journal of VitreoRetinal Diseases. Host Dr. Timothy Murray and Dr. Suñer review how vigilant ASRS members reported unusual black material in medication vials that was initially suspected to be fungal contamination but was identified as ru...
Intraocular Inflammation, Safety Events, and Outcomes After IVT Injection of Ranibizumab, Aflibercept, Brolucizumab, Abicipar Pegol, and Faricimab for nAMD
ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum
10 minutes
2 months ago
Intraocular Inflammation, Safety Events, and Outcomes After IVT Injection of Ranibizumab, Aflibercept, Brolucizumab, Abicipar Pegol, and Faricimab for nAMD
On this episode of the JVRD Author’s Forum podcast, Dr. Marta Stevanovic of the Massachusetts Eye and Ear Infirmary at Harvard Medical School discusses “Intraocular Inflammation, Safety Events, and Outcomes After Intravitreal Injection of Ranibizumab, Aflibercept, Brolucizumab, Abicipar Pegol, and Faricimab for nAMD,” published in the July/August 2025 issue of JVRD. Host Dr. Timothy Murray and Dr. Stevanovic review her team’s network meta-analysis of phase 3 clinical trial data comparing anti...
ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum
On this episode of the JVRD Author's Forum podcast, Dr. Ivan Suñer of Retina Associates of Florida discusses "Coring of Intravitreal Medication Vial Stoppers: A Report from the REST Committee," published in the September/October 2025 issue of the Journal of VitreoRetinal Diseases. Host Dr. Timothy Murray and Dr. Suñer review how vigilant ASRS members reported unusual black material in medication vials that was initially suspected to be fungal contamination but was identified as ru...
